News & Media

Events
Interim Report, January - June 2021

Read more
Events
ABGSC Life Science Summit

Read more
Events
Annual General Meeting 2021

Read more
Events
Interim Report, January - March 2021

Read more
Events
Kempen Life Sciences Conference - 2021 Thematic Virtual Series

Read more
Events
H.C. Wainwright Global Life Sciences Conference

Read more
Press release
Medivir to present at the H.C. Wainwright Global Life Sciences Conference

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the virtual meeting H.C. Wainwright...

Read more
Press release
MEDIVIR AB – YEAR-END REPORT JANUARY – DECEMBER 2020

October – December Financial summary for the quarter Net turnover amounted to SEK 1.5 (1.4) million. The profit before interest, tax,...

Read more
Press release
Number of shares and votes in Medivir

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the number of shares and votes in Medivir has changed...

Read more
Press release
Medivir enters into licensing agreement with Ubiquigent for preclinical program USP7

Stockholm, Sweden— Medivir AB (Nasdaq Stockholm: MVIR) announced today that it had entered into a license agreement with Ubiquigent Limited (Ubiquigent)...

Read more
Press release
MEDIVIR ANNOUNCES FINAL OUTCOME OF THE OVERSUBSCRIBED RIGHTS ISSUE AND RESOLVES ON OVER-ALLOTMENT

The final result of Medivir AB’s (publ) (“Medivir” or the “Company”) rights issue of approximately SEK 170 million (the “Rights Issue”)...

Read more
Press release
Notice of extraordinary general meeting of Medivir AB (publ)

The shareholders of Medivir AB, reg. no. 556238-4361, with its registered office in Huddinge, Stockholm, are hereby summoned to the extraordinary...

Read more